Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).
Zitouni J, Bursztejn AC, Belloni Fortina A, Beauchet A, Di Lernia V, Lesiak A, Thomas J, Topkarci Z, Murashkin N, Brzezinski P, Torres T, Chiriac A, Luca C, McPherson T, Akinde M, Maruani A, Epishev R, Vidaurri de la Cruz H, Luna PC, Amy de la Bretêque M, Lasek A, Bourrat E, Bachelerie M, Mallet S, Steff M, Bellissen A, Neri I, Zafiriou E, van den Reek JMPA, Sonkoly E, Mahil SK, Smith CH, Flohr C, Bachelez H, Mahé E; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology (BPSD), and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Zitouni J, et al. Among authors: mahil sk. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2076-2086. doi: 10.1111/jdv.18361. Epub 2022 Jul 6. J Eur Acad Dermatol Venereol. 2022. PMID: 35748102 Free PMC article.
Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris.
Berki DM, Mahil SK, David Burden A, Trembath RC, Smith CH, Capon F, Barker JN. Berki DM, et al. Among authors: mahil sk. J Invest Dermatol. 2014 Jan;134(1):271-273. doi: 10.1038/jid.2013.285. Epub 2013 Jun 21. J Invest Dermatol. 2014. PMID: 23792462 Free article. No abstract available.
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).
Mahil SK, Wilson N, Dand N, Reynolds NJ, Griffiths CEM, Emsley R, Marsden A, Evans I, Warren RB, Stocken D, Barker JN, Burden AD, Smith CH; BADBIR study group and the PSORT consortium. Mahil SK, et al. Br J Dermatol. 2020 May;182(5):1158-1166. doi: 10.1111/bjd.18333. Epub 2019 Sep 10. Br J Dermatol. 2020. PMID: 31286471 Free PMC article.
Psoriasis biologics: a new era of choice.
Mahil SK, Smith CH. Mahil SK, et al. Lancet. 2019 Sep 7;394(10201):807-808. doi: 10.1016/S0140-6736(19)31772-6. Epub 2019 Aug 8. Lancet. 2019. PMID: 31402113 No abstract available.
Psoriasis and Genetics.
Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Dand N, et al. Among authors: mahil sk. Acta Derm Venereol. 2020 Jan 30;100(3):adv00030. doi: 10.2340/00015555-3384. Acta Derm Venereol. 2020. PMID: 31971603 Free PMC article. Review.
68 results